Dr. Albert Wu to oversee Turn Biotechnologies product development

Albert Wu, MD, PhD, has joined Turn Biotechnologies, a cell rejuvenation company, to oversee development of ophthalmic therapeutic products. 

Read the full post on Becker's ASC

Becker's ASC